Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arginine vasopressin-induced protein 1 (AVPI1) is a human protein encoded by the AVPI1 gene, which is predicted to participate in signaling pathways such as the positive regulation of the MAP kinase (MAPK) cascade, down-regulation of the epithelial sodium channel (ENaC), and control of the cell cycle[2][3][4][8]. Its precise molecular function and physiological role remain incompletely characterized, and it is not currently classified as a classical therapeutic target, such as a receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arginine vasopressin-induced protein 1 (AVPI1).